In a significant step forward in medical science, researchers from Northwell Health’s Feinstein Institutes for Medical Research have successfully conducted the first double neural bypass operation - employing our Utah Array. Keith Thomas, a 45-year-old man paralyzed from the chest down due to a diving accident, is the first to experience the transformative results of this operation. The researchers successfully implanted our Utah Array into specific regions of Thomas's brain to stimulate motion and feeling. When Thomas visualizes a movement, our device captures the electrical signals in his brain and relays them to a computer that decodes the signals and stimulates the appropriate muscles, thus facilitating the movement Thomas imagines. The same process aids in restoring Thomas's sense of touch. Sensors on his skin send signals to the computer, which communicates with the Utah Arrays in his brain, enabling him to experience tactile sensations once again. Post-operation, Thomas has demonstrated significant progress, regaining the ability to move his arms and feel sensations on his skin. This operation marks a remarkable advancement in paralysis research and brain-computer interfacing, taking a giant leap forward in our understanding and ability to restore mobility and sensation in individuals affected by paralysis. Read the full TIME story and watch Keith's story here: https://lnkd.in/g9exCUhW #BCI #Neurotech #Medtech #Neuroscience #Technology #Paralysis #Braincomputerinterface
Blackrock Neurotech
Herstellung medizinischer Geräte
Salt Lake City, Utah 25,382 followers
Implantable brain technology that changes lives.
Über uns
Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today. Connect with us: Join Our Team | https://bit.ly/3bCsXRv LinkedIn | https://bit.ly/3PfifOL Twitter | https://bit.ly/3PfifOL Instagram | https://bit.ly/3bMaYrW Facebook | https://bit.ly/3JRc2av Clinical Trials | https://bit.ly/3A8QPWm Our site | https://blackrockneurotech.com Additional information: As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications. Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023. Join us in changing lives today.
- Website
-
Blackrockneurotech.com
External link for Blackrock Neurotech
- Industrie
- Herstellung medizinischer Geräte
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- Salt Lake City, Utah
- Typ
- In Privatbesitz
- Gegründet
- 2008
- Spezialitäten
- neuroscience, brain-computer interface, bci, neurotech, medical devices, neurotechnology, medical technology, biotechnology, brain chip, neurology, tech, biotech, medtech, brain computer interface, Utah Array, NeuroPort Array, Paralysis, Neurological disorders, Restoration, Communication, Mobility, Touch, and Sensation
Standorte
-
Primäre
n/a
Salt Lake City, Utah 84108, US
Employees at Blackrock Neurotech
Aktualisierungen
-
Blackrock Neurotech reposted this
We're excited to have spent time with the brilliant CNN Decoded team. We're even more excited for you to tune in this Sunday and see how our brain-computer interface technology is changing lives, today. #CNNDecoded #Neurotech
-
We're excited to have spent time with the brilliant CNN Decoded team. We're even more excited for you to tune in this Sunday and see how our brain-computer interface technology is changing lives, today. #CNNDecoded #Neurotech
-
Morning Brew talks brain-computer interfaces (BCI) with the best of the best (Ian Burkhart & Harrison Canning). With all the buzz around BCIs, it's exciting to see Blackrock Neurotech's groundbreaking work in the spotlight. Our adaptive BCI technology ensures consistent performance over time, leveraging AI to decode complex brain signals, opening up a world of possibilities for restoring and enhancing human capabilities. While we've already seen remarkable results, notably in the restoration of movement, communication, and sensation—we're just getting started. The potential applications of BCI technology are incredible: • Mental Health: Revolutionary treatments for depression, PTSD, and ADHD • Neurological Disorders: New approaches to epilepsy, Parkinson's, ALS, and Alzheimer's • Sensory Restoration: Groundbreaking possibilities for vision and hearing restoration • Pain Management: Innovative solutions for chronic pain At Blackrock Neurotech, we're committed to pushing the boundaries of what's possible with BCI technology. We're not just developing devices; we're opening new frontiers in human capability. Watch the full video here: 🔗 https://lnkd.in/gP39MQQK
-
Blackrock Neurotech reposted this
Want all the best in #BCI in one place? You're welcome! Join execs from Blackrock Neurotech, Motif Neurotech, ONWARD Medical, Paradromics Inc., Precision Neuroscience, and Synchron at #EMBC2024 on July 18 for a reprise of "BCI: State of the Art, Art of the future." Register today at https://lnkd.in/gxjZg4Du Presented by Neo-Bionica
-
-
Join us today at 7PM ET for an expert panel discussion with EverythingALS, featuring our own Spencer Kellis. Register here: https://lnkd.in/gAhzQ3yG
Events | EverythingALS
everythingals.org
-
Blackrock Neurotech reposted this
James Johnson's story is nothing short of awe-inspiring. A former respiratory therapist and adventure-seeker, James was paralyzed from the neck down after a paramotor accident almost a decade ago. Despite this major setback, he became one of the few dozen individuals implanted with BCI technology, and has accomplished a number of scientific and creative feats — from controlling robotic arms to creating stunning art in Photoshop. This past month, I spoke at the United Nations AI for Good summit alongside James and researcher Jorge Arturo G. from Caltech for a wide-ranging conversation on Brain-Computer Interfaces (BCIs) and the revolutionary potential they hold for accessibility and human capability. We discussed: - The incredible advancements in neurotechnology that allow control of devices with the mind. - James’ inspiring personal story as a respiratory therapist whose life was forever changed after a paramotor accident. - Insights from Jorge on the science behind BMIs - Real-world applications of BMIs in art, daily activities, and potentially disaster response. A special thanks to Sumner L Norman for setting the stage for this conversation. You can find the full conversation here: https://lnkd.in/gCQvWyUY CC// International Telecommunication Union Blackrock Neurotech
-
Blackrock Neurotech reposted this
Dive into the future of Brain-Computer Interfaces (BCI) at the ground-breaking NeuraSeed BCI Expo 2024: A Virtual World's Fair for BCI on August 2nd! Don’t miss this exclusive opportunity to network with BCI pioneers, explore cutting-edge research, and experience firsthand the latest advancements in the field.🧠💻 Ready to revolutionize the BCI landscape? Secure your spot now: https://lnkd.in/eXvQ3nRF. Want to showcase your research or product? Become a virtual exhibitor: https://lnkd.in/eaxDNFKf. Let's shape the future together! #NeuraSeedBCIExpo2024 #Neurotechnology #BCI #Innovation
-
-
“I think we’re reaching the pinnacle in the development of this technology in concert with AI, to where these things are a real possibility, now. It’s not just 'what ifs'. It’s 'when' at this point," says Pioneering BCI user, James Johnson. An amazing representation of minds and technology convergence on the stage at the United Nations' AI for Good summit, including James, Caltech's Jorge Arturo G., Taryn Southern, and host Sumner L Norman for this conversation. Absolutely brilliant.
-
Major depressive disorder (MDD) is a leading cause of disability worldwide, affecting over 300 million people. For approximately 30% of patients, standard treatments prove ineffective, leading to treatment resistant depression (TRD). That’s ~90 million people living with TRD, or the combined populations of the entire states of California, New York, and Florida. Notably, a key characteristic of MDD is a bias towards negative information processing and away from positive information processing. As this phenomena may perpetuate the disorder, understanding the neural basis of this emotional bias is crucial for developing more targeted, effective treatments. Researchers from Baylor College of Medicine's Kelly Bijanki Lab took advantage of a unique opportunity to record intracranial EEG in patients with TRD with an epilepsy control group while they rated emotional faces. Blackrock Neurotech's Cerebus data acquisition system was instrumental in capturing this neural data with high spatiotemporal precision. The findings revealed separate neural mechanisms driving the emotion processing bias in TRD: 1. Early (~300ms) increased amygdala response to sad faces, suggesting overactive bottom-up emotion processing 2. Late (~600ms) decreased amygdala response to happy faces, likely due to increased top-down inhibition from the prefrontal cortex (PFC) via enhanced alpha oscillations 3. Greater alpha-band power in the PFC and alpha-synchrony between the PFC and amygdala during the late stage of processing happy faces Remarkably, following deep brain stimulation targeting key depression network nodes, the TRD group's abnormal neural dynamics shifted to resemble the control group more closely, particularly for happy face processing. This study provides exceptional insight into the neural circuitry underlying the negative bias in TRD and how neuromodulation may help normalize emotional processing. The findings have significant implications for advancing our understanding of depression pathophysiology and innovating more effective, targeted treatments for this debilitating disorder. We applaud this brilliant research team for this groundbreaking work and are proud that our leading-edge neurotechnology played a key role in this discovery. Read the full paper in Nature Portfolio: https://lnkd.in/gUwcXcSk #Neurotech #MentalHealthAwareness #Research #DBS #MDD #Neuroscience
Brain mechanisms underlying the emotion processing bias in treatment-resistant depression - Nature Mental Health
nature.com